GVK Biosciences (GVK BIO) announced that it was awarded the Frost & Sullivan 2011 Best Practices Award for Growth Leadership in the Contract Research Services Market.
The Frost & Sullivan Award for Growth Leadership is presented to the company that has demonstrated excellence in capturing an impressive growth rate. The Growth Leadership Award is a prestigious recognition of GVK BIO’s accomplishments in the Contract Research Service Market. With over ten years of experience and with more than 2000 employees, GVK BIO offers a spectrum of stand- alone and integrated services across the life Sciences R&D value chain.
“GVK BIO has skilfully forward and upward integrated its service portfolio in sync with the changing pharma & biotech environment. Their recent milestones in discovery validate GVK BIO's ability and leadership in discovery programs.” quoted Dr Ajaykumar Sharma, Frost & Sullivan's Industry Manager - Pharma and Biotech.
Frost further highlights that GVK BIO has consistently grown by strengthening its leadership position in R&D Services, venturing into new service lines (such as parallel medicinal chemistry, biomarker products) and focusing on key process improvements such as productivity, scientific depth and project management. GVK BIO’s flexibility to change direction with change in customer priorities and constant endeavour to beat benchmarks, received good feedback from their clients.
Commenting on the award, Manni Kantipudi, Chief Executive Officer, GVK Biosciences said, “In a tough environment, GVK BIO has emerged a leader and has won this Growth Leadership Award in the Contract Research segment. Our commitment to our customers of delivering innovative, timely, and cost effective solutions has led to this award and we remain committed to delivering great value to our customers. I am delighted to receive this award from a reputed organization like Frost and Sullivan”.